James M. Ervasti

12.6k total citations · 3 hit papers
117 papers, 10.2k citations indexed

About

James M. Ervasti is a scholar working on Molecular Biology, Cell Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, James M. Ervasti has authored 117 papers receiving a total of 10.2k indexed citations (citations by other indexed papers that have themselves been cited), including 112 papers in Molecular Biology, 36 papers in Cell Biology and 33 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in James M. Ervasti's work include Muscle Physiology and Disorders (90 papers), Exercise and Physiological Responses (30 papers) and Cardiomyopathy and Myosin Studies (27 papers). James M. Ervasti is often cited by papers focused on Muscle Physiology and Disorders (90 papers), Exercise and Physiological Responses (30 papers) and Cardiomyopathy and Myosin Studies (27 papers). James M. Ervasti collaborates with scholars based in United States, France and Australia. James M. Ervasti's co-authors include Kevin P. Campbell, Kay Ohlendieck, Steven D. Kahl, Inna N. Rybakova, Benjamin J. Perrin, Suzanne W. Sernett, Clive A. Slaughter, Oxana Ibraghimov‐Beskrovnaya, Kiichiro Matsumura and Kevin J. Sonnemann and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

James M. Ervasti

116 papers receiving 10.0k citations

Hit Papers

Primary structure of dystrophin-associated glycoproteins ... 1990 2026 2002 2014 1992 1991 1990 250 500 750 1000

Peers

James M. Ervasti
Caroline A. Sewry United Kingdom
John McAnally United States
Steven J. Burden United States
Bradley B. Olwin United States
Nicholas W. Gale United States
Christiana Ruhrberg United Kingdom
Caroline A. Sewry United Kingdom
James M. Ervasti
Citations per year, relative to James M. Ervasti James M. Ervasti (= 1×) peers Caroline A. Sewry

Countries citing papers authored by James M. Ervasti

Since Specialization
Citations

This map shows the geographic impact of James M. Ervasti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James M. Ervasti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James M. Ervasti more than expected).

Fields of papers citing papers by James M. Ervasti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James M. Ervasti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James M. Ervasti. The network helps show where James M. Ervasti may publish in the future.

Co-authorship network of co-authors of James M. Ervasti

This figure shows the co-authorship network connecting the top 25 collaborators of James M. Ervasti. A scholar is included among the top collaborators of James M. Ervasti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James M. Ervasti. James M. Ervasti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Southern, William M., et al.. (2022). Nucleotide- and Protein-Dependent Functions of Actg1. Molecular Biology of the Cell. 33(9). ar77–ar77. 8 indexed citations
2.
Ryan, Terence E., Cameron A. Schmidt, Michael D. Tarpey, et al.. (2020). PFKFB3-mediated glycolysis rescues myopathic outcomes in the ischemic limb. JCI Insight. 5(18). 25 indexed citations
3.
Lindsay, Angus, Reem Abo‐Zahrah, Kristen A. Baltgalvis, et al.. (2018). Loss of peroxiredoxin-2 exacerbates eccentric contraction-induced force loss in dystrophin-deficient muscle. Nature Communications. 9(1). 5104–5104. 30 indexed citations
4.
Lindsay, Angus, et al.. (2018). Xanthine oxidase is hyper-active in Duchenne muscular dystrophy. Free Radical Biology and Medicine. 129. 364–371. 24 indexed citations
5.
Chamberlain, Christopher M., et al.. (2017). Relative importance of βcyto- and γcyto-actin in primary mouse embryonic fibroblasts. Molecular Biology of the Cell. 28(6). 771–782. 26 indexed citations
6.
Cheever, Thomas R., Bin Li, & James M. Ervasti. (2012). Restricted Morphological and Behavioral Abnormalities following Ablation of β-Actin in the Brain. PLoS ONE. 7(3). e32970–e32970. 35 indexed citations
7.
Piazza, Valeria, Benjamin J. Perrin, Agnieszka Rzadzinska, et al.. (2012). Multi-isotope imaging mass spectrometry reveals slow protein turnover in hair-cell stereocilia. Nature. 481(7382). 520–524. 174 indexed citations
8.
Henderson, Davin M., Joseph J. Belanto, Bin Li, Hanke Heun‐Johnson, & James M. Ervasti. (2011). Internal deletion compromises the stability of dystrophin. Human Molecular Genetics. 20(15). 2955–2963. 32 indexed citations
9.
Henderson, Davin M., et al.. (2011). The Carboxy-Terminal Third of Dystrophin Enhances Actin Binding Activity. Journal of Molecular Biology. 416(3). 414–424. 15 indexed citations
10.
Ervasti, James M., et al.. (2010). Delayed embryonic development and impaired cell growth and survival in Actg1 null mice. Cytoskeleton. 67(9). 564–572. 77 indexed citations
11.
Prins, Kurt W., et al.. (2009). Dystrophin is a microtubule-associated protein. The Journal of Cell Biology. 186(3). 363–369. 153 indexed citations
12.
Ervasti, James M.. (2006). Dystrophin, its interactions with other proteins, and implications for muscular dystrophy. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1772(2). 108–117. 241 indexed citations
13.
Ervasti, James M.. (2003). Costameres: the Achilles' Heel of Herculean Muscle. Journal of Biological Chemistry. 278(16). 13591–13594. 333 indexed citations
14.
Rybakova, Inna N., Jitandrakumar R. Patel, Kay E. Davies, Peter D. Yurchenco, & James M. Ervasti. (2002). Utrophin Binds Laterally along Actin Filaments and Can Couple Costameric Actin with Sarcolemma When Overexpressed in Dystrophin-deficient Muscle. Molecular Biology of the Cell. 13(5). 1512–1521. 84 indexed citations
15.
Rybakova, Inna N., et al.. (2001). Dystrophin and utrophin are functionally homologous actin binding proteins but act through distinct modes of filament association. Molecular Biology of the Cell. 12. 1 indexed citations
16.
Amann, Kurt J., Athena Guo, & James M. Ervasti. (1999). Utrophin Lacks the Rod Domain Actin Binding Activity of Dystrophin. Journal of Biological Chemistry. 274(50). 35375–35380. 55 indexed citations
17.
Ervasti, James M., Steven L. Roberds, Richard D. Anderson, et al.. (1994). α‐Dystroglycan deficiency correlates with elevated serum creatine kinase and decreased muscle contraction tension in golden retriever muscular dystrophy. FEBS Letters. 350(2-3). 173–176. 12 indexed citations
18.
Matsumura, Kiichiro, F.M.S. Tomé, Victor Ionâşescu, et al.. (1993). Deficiency of dystrophin-associated proteins in Duchenne muscular dystrophy patients lacking COOH-terminal domains of dystrophin.. Journal of Clinical Investigation. 92(2). 866–871. 60 indexed citations
19.
Ervasti, James M. & Kevin P. Campbell. (1991). Membrane organization of the dystrophin-glycoprotein complex. Cell. 66(6). 1121–1131. 1107 indexed citations breakdown →
20.
Ervasti, James M., James R. Mickelson, Scott M. Lewis, David D. Thomas, & Charles F. Louis. (1989). An electron paramagnetic resonance study of skeletal muscle membrane fluidity in malignant hyperthermia. Biochimica et Biophysica Acta (BBA) - Biomembranes. 986(1). 70–74. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026